/Investor DB

Gurnet Point Capital — 2018 Investments

1 investments dated 2018 · listed companies and verified rows first · show all

Macrolide PharmaceuticalsinApr 2018 · $20M

BiotechWatertown, US

Edward Mascioli(Executive Officer)Andrew Myers(Director)

BoardMarkus Goebel(Director)Henry Skinner(Director)inVikas Goyal(Director)Raj Parekh(Director)in

Co-investorsAdvent Life SciencesNovartis Venture FundRoche Venture Fund

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.